7 results on '"Klyuzhin, Ivan S."'
Search Results
2. Multi-tracer PET correlation analysis reveals disease-specific patterns in Parkinson’s disease and asymptomatic LRRK2 pathogenic variant carriers compared to healthy controls
- Author
-
Mannheim, Julia G., Fu, Jessie Fanglu, Wegener, Tilman, Klyuzhin, Ivan S., Vafai, Nasim, Shahinfard, Elham, McKenzie, Jessamyn, Strongosky, Audrey, Wszolek, Zbigniew K., Jon Stoessl, A., and Sossi, Vesna
- Published
- 2024
- Full Text
- View/download PDF
3. Contralateral Hypertrophy Post Yttrium-90 Transarterial Radioembolization in Patients With Hepatocellular Carcinoma and Portal Vein Tumor Thrombus
- Author
-
Hadjivassiliou, Anastasia, primary, Hou, Xinchi, additional, Cardarelli-Leite, Leandro, additional, Klyuzhin, Ivan S, additional, Bénard, François, additional, Klass, Darren, additional, Ho, Stephen G.F., additional, Rahmim, Arman, additional, and Liu, David, additional
- Published
- 2024
- Full Text
- View/download PDF
4. Evaluating Outcome Prediction via Baseline, End-of-Treatment, and Delta Radiomics on PET-CT Images of Primary Mediastinal Large B-Cell Lymphoma
- Author
-
Yousefirizi, Fereshteh, primary, Gowdy, Claire, additional, Klyuzhin, Ivan S., additional, Sabouri, Maziar, additional, Tonseth, Petter, additional, Hayden, Anna R., additional, Wilson, Donald, additional, Sehn, Laurie H., additional, Scott, David W., additional, Steidl, Christian, additional, Savage, Kerry J., additional, Uribe, Carlos F., additional, and Rahmim, Arman, additional
- Published
- 2024
- Full Text
- View/download PDF
5. Relating Macroscopic PET Radiomics Features to Microscopic Tumor Phenotypes Using a Stochastic Mathematical Model of Cellular Metabolism and Proliferation.
- Author
-
Ahn, Hailey S. H., Oloumi Yazdi, Yas, Wadsworth, Brennan J., Bennewith, Kevin L., Rahmim, Arman, and Klyuzhin, Ivan S.
- Subjects
TUMOR diagnosis ,RESEARCH funding ,RADIOMICS ,CELL proliferation ,POSITRON emission tomography ,XENOGRAFTS ,DESCRIPTIVE statistics ,MATHEMATICAL models ,TUMORS ,THEORY ,PHENOTYPES - Abstract
Simple Summary: Radiomics analysis of positron emission tomography (PET) images can provide objective measurements of tumor heterogeneity and spatial patterns. However, the relatively low resolution, high noise, and limited longitudinal data availability make it difficult to systematically investigate the relationship between the microscopic tumor phenotypes and corresponding PET radiomics signatures. To address this challenge, we use a multiscale, stochastic mathematical model of tumor growth to generate cross-sections of tumors in vascularized normal tissue on a microscopic level. By varying the biological parameters of the model, distinct tumor phenotypes are obtained, and their corresponding PET images are generated. The simulated data are then used to find the optimal combination of PET radiomics features that can reliably distinguish visually similar tumor phenotypes. In addition, we study the longitudinal changes in the discriminative power of radiomics features with tumor growth from a single cell to approximately one million cells. Cancers can manifest large variations in tumor phenotypes due to genetic and microenvironmental factors, which has motivated the development of quantitative radiomics-based image analysis with the aim to robustly classify tumor phenotypes in vivo. Positron emission tomography (PET) imaging can be particularly helpful in elucidating the metabolic profiles of tumors. However, the relatively low resolution, high noise, and limited PET data availability make it difficult to study the relationship between the microenvironment properties and metabolic tumor phenotype as seen on the images. Most of previously proposed digital PET phantoms of tumors are static, have an over-simplified morphology, and lack the link to cellular biology that ultimately governs the tumor evolution. In this work, we propose a novel method to investigate the relationship between microscopic tumor parameters and PET image characteristics based on the computational simulation of tumor growth. We use a hybrid, multiscale, stochastic mathematical model of cellular metabolism and proliferation to generate simulated cross-sections of tumors in vascularized normal tissue on a microscopic level. The generated longitudinal tumor growth sequences are converted to PET images with realistic resolution and noise. By changing the biological parameters of the model, such as the blood vessel density and conditions for necrosis, distinct tumor phenotypes can be obtained. The simulated cellular maps were compared to real histology slides of SiHa and WiDr xenografts imaged with Hoechst 33342 and pimonidazole. As an example application of the proposed method, we simulated six tumor phenotypes that contain various amounts of hypoxic and necrotic regions induced by a lack of oxygen and glucose, including phenotypes that are distinct on the microscopic level but visually similar in PET images. We computed 22 standardized Haralick texture features for each phenotype, and identified the features that could best discriminate the phenotypes with varying image noise levels. We demonstrated that "cluster shade" and "difference entropy" are the most effective and noise-resilient features for microscopic phenotype discrimination. Longitudinal analysis of the simulated tumor growth showed that radiomics analysis can be beneficial even in small lesions with a diameter of 3.5–4 resolution units, corresponding to 8.7–10.0 mm in modern PET scanners. Certain radiomics features were shown to change non-monotonically with tumor growth, which has implications for feature selection for tracking disease progression and therapy response. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
6. PSMA‐Hornet: Fully‐automated, multi‐target segmentation of healthy organs in PSMA PET/CT images.
- Author
-
Klyuzhin, Ivan S., Chaussé, Guillaume, Bloise, Ingrid, Harsini, Sara, Ferres, Juan Lavista, Uribe, Carlos, and Rahmim, Arman
- Subjects
- *
COMPUTED tomography , *RADIATION dosimetry , *IMAGE analysis , *NETWORK performance , *TASK analysis , *POSITRON emission tomography , *IMAGE segmentation - Abstract
Background: Prostate‐specific membrane antigen (PSMA) PET imaging represents a valuable source of information reflecting disease stage, response rate, and treatment optimization options, particularly with PSMA radioligand therapy. Quantification of radiopharmaceutical uptake in healthy organs from PSMA images has the potential to minimize toxicity by extrapolation of the radiation dose delivery towards personalization of therapy. However, segmentation and quantification of uptake in organs requires labor‐intensive organ delineations that are often not feasible in the clinic nor scalable for large clinical trials. Purpose: In this work we develop and test the PSMA Healthy organ segmentation network (PSMA‐Hornet), a fully‐automated deep neural net for simultaneous segmentation of 14 healthy organs representing the normal biodistribution of [18F]DCFPyL on PET/CT images. We also propose a modified U‐net architecture, a self‐supervised pre‐training method for PET/CT images, a multi‐target Dice loss, and multi‐target batch balancing to effectively train PSMA‐Hornet and similar networks. Methods: The study used manually‐segmented [18F]DCFPyL PET/CT images from 100 subjects, and 526 similar images without segmentations. The unsegmented images were used for self‐supervised model pretraining. For supervised training, Monte‐Carlo cross‐validation was used to evaluate the network performance, with 85 subjects in each trial reserved for model training, 5 for validation, and 10 for testing. Image segmentation and quantification metrics were evaluated on the test folds with respect to manual segmentations by a nuclear medicine physician, and compared to inter‐rater agreement. The model's segmentation performance was also evaluated on a separate set of 19 images with high tumor load. Results: With our best model, the lowest mean Dice coefficient on the test set was 0.826 for the sublingual gland, and the highest was 0.964 for liver. The highest mean error in tracer uptake quantification was 13.9% in the sublingual gland. Self‐supervised pretraining improved training convergence, train‐to‐test generalization, and segmentation quality. In addition, we found that a multi‐target network produced significantly higher segmentation accuracy than single‐organ networks. Conclusions: The developed network can be used to automatically obtain high‐quality organ segmentations for PSMA image analysis tasks. It can be used to reproducibly extract imaging data, and holds promise for clinical applications such as personalized radiation dosimetry and improved radioligand therapy. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
7. From code sharing to sharing of implementations: Advancing reproducible AI development for medical imaging through federated testing.
- Author
-
Yousefirizi F, Liyanage A, Klyuzhin IS, and Rahmim A
- Abstract
Background: The reproducibility crisis in AI research remains a significant concern. While code sharing has been acknowledged as a step toward addressing this issue, our focus extends beyond this paradigm. In this work, we explore "federated testing" as an avenue for advancing reproducible AI research and development especially in medical imaging. Unlike federated learning, where a model is developed and refined on data from different centers, federated testing involves models developed by one team being deployed and evaluated by others, addressing reproducibility across various implementations., Methods: Our study follows an exploratory design aimed at systematically evaluating the sources of discrepancies in shared model execution for medical imaging and outputs on the same input data, independent of generalizability analysis. We distributed the same model code to multiple independent centers, monitoring execution in different runtime environments while considering various real-world scenarios for pre- and post-processing steps. We analyzed deployment infrastructure by comparing the impact of different computational resources (GPU vs. CPU) on model performance. To assess federated testing in AI models for medical imaging, we performed a comparative evaluation across different centers, each with distinct pre- and post-processing steps and deployment environments, specifically targeting AI-driven positron emission tomography (PET) imaging segmentation. More specifically, we studied federated testing for an AI-based model for surrogate total metabolic tumor volume (sTMTV) segmentation in PET imaging: the AI algorithm, trained on maximum intensity projection (MIP) data, segments lymphoma regions and estimates sTMTV., Results: Our study reveals that relying solely on open-source code sharing does not guarantee reproducible results due to variations in code execution, runtime environments, and incomplete input specifications. Deploying the segmentation model on local and virtual GPUs compared to using Docker containers showed no effect on reproducibility. However, significant sources of variability were found in data preparation and pre-/post- processing techniques for PET imaging. These findings underscore the limitations of code sharing alone in achieving consistent and accurate results in federated testing., Conclusion: Achieving consistently precise results in federated testing requires more than just sharing models through open-source code. Comprehensive pipeline sharing, including pre- and post-processing steps, is essential. Cloud-based platforms that automate these processes can streamline AI model testing across diverse locations. Standardizing protocols and sharing complete pipelines can significantly enhance the robustness and reproducibility of AI models., (Copyright © 2024. Published by Elsevier Inc.)
- Published
- 2024
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.